Prevalence, awareness, treatment, control and risk factors related to hypertension among urban adults in Inner Mongolia 2014: Differences between Mongolian and Han populations

BMC Public Health

Volumn 16, Issue 1, 2016, Pages

  Li, Guoju ^a   Wang, Hailing ^b   Wang, Ke ^a   Wang, Wenrui ^b   Dong, Fen ^a   Qian, Yonggang ^b   Gong, Haiying ^a   Xu, Guodong ^c   Li, Yanlong ^a   Pan, Li ^a   Wang, Bin ^a   Zhu, Guangjin ^a   Shan, Guangliang ^a  

^a INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

^b Inner Mongolia Center for Disease Control and Prevention   (China)

^c JILIN UNIVERSITY   (China)

Author keywords

Ethnicity; Han; Hypertension; Mongolian; Urban

Indexed keywords

ADULT; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; ATTITUDE TO HEALTH; CHINA; COMPARATIVE STUDY; EPIDEMIOLOGY; ETHNIC GROUP; ETHNOLOGY; FEMALE; HUMAN; HYPERTENSION; MALE; MIDDLE AGED; PREVALENCE; RISK FACTOR; STATISTICAL MODEL; STATISTICS AND NUMERICAL DATA; URBAN POPULATION; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; ASIAN CONTINENTAL ANCESTRY GROUP; CHINA; ETHNIC GROUPS; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; HYPERTENSION; LOGISTIC MODELS; MALE; MIDDLE AGED; PREVALENCE; RISK FACTORS; URBAN POPULATION; YOUNG ADULT;

EID: 84977560564     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/s12889-016-2965-5     Document Type: Article

References (32)

1. Narayan KM, Ali MK, Koplan JP. Global noncommunicable diseases - where worlds meet. N Engl J Med. 2010;363(13):1196-8.
2. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: analysis of worldwide data. Lancet. 2005;365(9455):217-23.
3. Joshi P, Islam S, Pais P, Reddy S, Dorairaj P, Kazmi K, Pandey MR, Haque S, Mendis S, Rangarajan S et al. Risk factors for early myocardial infarction in South Asians compared with individuals in other countries. JAMA. 2007;297(3):286-94.
4. Teo KK, Liu L, Chow CK, Wang X, Islam S, Jiang L, Sanderson JE, Rangarajan S, Yusuf S. Potentially modifiable risk factors associated with myocardial infarction in China: the INTERHEART China study. Heart. 2009;95(22):1857-64.
5. Hu SS, Kong LZ, Gao RL, Zhu ML, Wang W, Wang YJ, Wu ZS, Chen WW, Liu MB. Outline of the report on cardiovascular disease in China, 2010. Biomed Environ Sci. 2012;25(3):251-6.
6. Egan BM, Zhao YM, Axon RN. US Trends in Prevalence, Awareness, Treatment, and Control of Hypertension, 1988-2008. JAMA. 2010;303(20):2043-50.
7. Hotchkiss JW, Davies C, Gray L, Bromley C, Capewell S, Leyland AH. Trends in adult cardiovascular disease risk factors and their socio-economic patterning in the Scottish population 1995-2008: cross-sectional surveys. BMJ Open. 2011;1(1):e000176.
8. Chen X, Wei W, Zou S, Wu X, Zhou B, Fu L, Wang H, Shi J. Trends in the prevalence of hypertension in island and coastal areas of china: a systematic review with meta-analysis. Am J Hypertens. 2014;27(12):1503-10.
9. Ma YQ, Mei WH, Yin P, Yang XH, Rastegar SK, Yan JD. Prevalence of hypertension in Chinese cities: a meta-analysis of published studies. PLoS One. 2013;8(3):e58302.
10. Xi B, Liang Y, Reilly KH, Wang Q, Hu Y, Tang W. Trends in prevalence, awareness, treatment, and control of hypertension among Chinese adults 1991-2009. Int J Cardiol. 2012;158(2):326-9.
11. Liang YJ, Xi B, Hu YH, Wang C, Liu JT, Yan YK, Xu T, Wang RQ. Trends in blood pressure and hypertension among Chinese children and adolescents: China Health and Nutrition Surveys 1991-2004. Blood Press. 2011;20(1):45-53.
12. Zhai F, He Y, Wang Z, Hu Y. [Status and characteristic of dietary intake of 12 minority nationalities in China]. Wei Sheng Yan Jiu. 2007;36(5):539-41.
13. Roalfe AK, Holder RL, Wilson S. Standardisation of rates using logistic regression: a comparison with the direct method. BMC Health Serv Res. 2008;8:275.
14. Basu S, Millett C. Social epidemiology of hypertension in middle-income countries: determinants of prevalence, diagnosis, treatment, and control in the WHO SAGE study. Hypertension. 2013;62(1):18-26.
15. Meng XJ, Dong GH, Wang D, Liu MM, Lin Q, Tian S, Xu LX, Hou H, Ren YF, Lee YL. Prevalence, awareness, treatment, control, and risk factors associated with hypertension in urban adults from 33 communities of China: the CHPSNE study. J Hypertens. 2011;29(7):1303-10.
16. Li H, Xu T, Tong W, Liu Y, Zhao L, Zhang Y. Comparison of cardiovascular risk factors between prehypertension and hypertension in a Mongolian population, Inner Mongolia, China. Circ J. 2008;72(10):1666-73.
17. Organization WH. World Health Statistics 2015. 2015.
18. Tunstall-Pedoe H, Connaghan J, Woodward M, Tolonen H, Kuulasmaa K. Pattern of declining blood pressure across replicate population surveys of the WHO MONICA project, mid-1980s to mid-1990s, and the role of medication. BMJ. 2006;332(7542):629-35.
19. Li N, Wang H, Yan Z, Yao X, Hong J, Zhou L. Ethnic disparities in the clustering of risk factors for cardiovascular disease among the Kazakh, Uygur, Mongolian and Han populations of Xinjiang: a cross-sectional study. BMC Public Health. 2012;12:499.
20. Quan H, Chen G, Walker RL, Wielgosz A, Dai S, Tu K, Campbell NR, Hemmelgarn BR, Hill MD, Johansen H, et al. Incidence, cardiovascular complications and mortality of hypertension by sex and ethnicity. Heart. 2013;99(10):715-21.
21. Yao XG, Frommlet F, Zhou L, Zu F, Wang HM, Yan ZT, Luo WL, Hong J, Wang XL, Li NF. The prevalence of hypertension, obesity and dyslipidemia in individuals of over 30 years of age belonging to minorities from the pasture area of Xinjiang. BMC Public Health. 2010;10:91.
22. Yang S, Liu S, Wang Y, Wan H, Zhao D, Li Y, Chen SS, Wu Y, Dustin L, Azen S, et al. High blood pressure in Chinese ethnic minorities: report from rural Yunnan province. Am J Hypertens. 2011;24(11):1209-14.
23. Hasi T, Hao L, Yang L, Su XL. Acetaldehyde dehydrogenase 2 SNP rs671 and susceptibility to essential hypertension in Mongolians: a case control study. Genet Mol Res. 2011;10(1):537-43.
24. Black ML, Wang W, Bittles AH. A genome-based study of the Muslim Hui community and the Han population of Liaoning Province, PR China. Hum Biol. 2001;73(6):801-13.
25. Chang PY, Zhao LG, Su XL. Association of TSC gene variants and hypertension in Mongolian and Han populations. Genet Mol Res. 2011;10(2):902-9.
26. Calhoun DA, Jones D, Textor S, Goff DC, Murphy TP, Toto RD, White A, Cushman WC, White W, Sica D, et al. Resistant hypertension: diagnosis, evaluation, and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. Hypertension. 2008;51(6):1403-19.
27. Chow CK, Teo KK, Rangarajan S, Islam S, Gupta R, Avezum A, Bahonar A, Chifamba J, Dagenais G, Diaz R, et al. Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high-, middle-, and low-income countries. JAMA. 2013;310(9):959-68.
28. Gu H, Li W, Yang J, Wang Y, Bo J, Liu L. Hypertension prevalence, awareness, treatment and control among Han and four ethnic minorities (Uygur, Hui, Mongolian and Dai) in China. J Hum Hypertens. 2015;29:555-60.
29. Zaman MJ, Patel A, Jan S, Hillis GS, Raju PK, Neal B, Chow CK. Socio-economic distribution of cardiovascular risk factors and knowledge in rural India. Int J Epidemiol. 2012;41(5):1302-14.
30. Prince MJ, Ebrahim S, Acosta D, Ferri CP, Guerra M, Huang Y, Jacob KS, Jimenez-Velazquez IZ, Rodriguez JL, Salas A, et al. Hypertension prevalence, awareness, treatment and control among older people in Latin America, India and China: a 10/66 cross-sectional population-based survey. J Hypertens. 2012;30(1):177-87.
31. Cutler JA, Sorlie PD, Wolz M, Thom T, Fields LE, Roccella EJ. Trends in hypertension prevalence, awareness, treatment, and control rates in United States adults between 1988-1994 and 1999-2004. Hypertension. 2008;52(5):818-27.
32. Papathanasiou G, Zerva E, Zacharis I, Papandreou M, Papageorgiou E, Tzima C, Georgakopoulos D, Evangelou A. Association of high blood pressure with body mass index, smoking and physical activity in healthy young adults. Open Cardiovasc Med J. 2015;9:5-17.